Truncus Arteriosus Market Research Report - Global Forecast till 2027

Truncus Arteriosus Market Research Report Information: By Type (Type I, Type II, Type III) Diagnosis (Echocardiogram) Treatment (Medication, Surgery and Cardiac Catheterization) End User (Hospitals & Clinics, Cardiac Care Centers) – Global Forecast till 2027

ID: MRFR/MED/3822-HCR | | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario


Truncus arteriosus is a rare congenital heart disease/defect. If the baby has truncus arteriosus, it means that one large blood vessel leads out of the heart instead of two separate vessels. Moreover, in this condition, usually, there is a hole known as a ventricular septal defect present between the two lower chambers of the heart. As a result of truncus arteriosus, oxygen-poor blood that should go to the lungs and oxygen-rich blood that should go to the rest of the body are mixed together which leads to severe circulatory problems. However, if untreated, truncus arteriosus can be fatal.


The global truncus arteriosus market is expecting a sound growth in coming future owing to the increasing demand for various cardiovascular devices, increasing prevalence of cardiovascular diseases, and favorable reimbursement policies. In some cases, maternal diabetes may lead to truncus arteriosus. However, mostly all diabetic patients suffer from some or the other cardiovascular disease. According to the findings from the WHO in 2014, approximately 422 million people reported suffering from diabetes. Due to the increasing diabetic population across the globe, there is a significant increase in the number of people suffering from cardiovascular diseases. According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths of which 82% were in the low- and middle-income countries. Additionally, according to the Centers for Disease Control and Prevention (2015), over 630,000 Americans die from heart disease each year, which accounts for 1 in every 4 death.


Additionally, increasing geriatric population and increasing healthcare expenditure have fuelled the growth of this market. On the other hand, higher cost of the treatments may slow the growth of the market during the forecast period.


The Truncus Arteriosus Market is expected to grow at a CAGR of 7.8% during the forecast period 2017-2023.


Figure- Global Truncus Arteriosus Market, by region 2016(%)
Truncus Arteriosus Market


Intended Audience



  • Cardiovascular Products Manufacturers

  • Cardiovascular Products Providers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 


Key players in the global truncus arteriosus market:


Some of the major players in this market are Boston Scientific Corporation (U.S.), Coloplast (Denmark), Dispocard GmbH (Germany), St. Jude Medical (U.S.), Abbott Laboratories (U.S.), Johnson & Johnson (U.S.), Teleflex Incorporated (U.S.)., Smiths Medical (U.S.), Edwards Life Sciences Corporation (U.S.), Medtronic Inc (U.S.), Rochester Medical Corporation (U.S), Maquet Medical India Private Limited (India), Terumo Medical Corporation (Japan), AstraZeneca plc., Pfizer Inc., Novartis AG, Merck & Co., Inc., Bristol-Myers Squibb Company, Bayer AG, Sanofi, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Astellas Pharma, Inc., Eli Lilly and Company, Otsuka Holdings Co., Ltd., Takeda Pharmaceutical Company Limited.


Segments


The global truncus arteriosus market has been segmented on the basis of types, diagnosis, treatment, and end user.


On the basis of the types, the global truncus arteriosus market is segmented into type I, type II, type III.


Based on the diagnosis, it is segmented into echocardiogram and X-ray while on the basis of treatment the market is segmented into medication, surgery, cardiac catheterization, and others.


The medication segment can be further segmented into diuretics, ionotropic agents.


On the basis of the end users, the market is segmented into hospitals & clinics, cardiac care centers, ambulatory centers & home care, academic institutes, and others.


Research Methodology

Truncus Arteriosus Market 2018


Source: U.S. National Library of Medicine, U.S. Food and Drug Administration, U.S. Department of Health and Human Services, National Institutes of Health, Expert Interview, Annual report, White paper, Company Presentation, MRFR Analysis


Regional Analysis


The Americas accounted for the major share of the market owing to the presence of a huge population suffering from heart disease, high healthcare expenditure, well-developed technology, and the presence of the leading players in the region. Furthermore, rising government support for the development of the advanced devices and well-developed healthcare sector has boosted the growth of the truncus arteriosus market in the Americas.


Europe accounted for the second largest market for the truncus arteriosus, which is followed by Asia Pacific. Increasing prevalence of the cardiovascular diseases, diabetes, and huge healthcare spending are the major driving factors that have boosted the market growth. Additionally, the healthcare expenditure in this region is also rising. People and healthcare organizations in this region are able to afford the high cost of the cardiovascular devices, which is further fuelling the growth of the market. Furthermore, increasing government support and funding for the development and improvement of the treatments have also contributed to the growth of the market.


Asia Pacific is the fastest growing truncus arteriosus market. Increasing need for better devices, rapidly improving technology, and the presence of huge patient pool is driving the growth of the market in this region.  


The Middle East & Africa holds the least share of the market owing to the presence of poor and slow developing countries, especially, in the African region. The major driving factors for the growth of the Middle East & African truncus arteriosus market are increasing a number of diabetic and cardiovascular patients.



Frequently Asked Questions (FAQ) :


The truncus arteriosus market is projected to grow at a 7.8% CAGR between 2017-2023.

The Americas is projected to lead the truncus arteriosus market.

End users of the truncus arteriosus market include academic institutes, ambulatory centers and home care, cardiac care centers, and hospitals & clinics.

Increasing healthcare expenditure and favorable reimbursement policies are the key factors driving the truncus arteriosus market growth.

High treatment cost may limit the truncus arteriosus market growth.

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Truncus Arteriosus Market, By Type

6.1 Introduction

6.2 Type I

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Type II

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Type III

6.4.1 Market Estimates & Forecast, 2020-2027

7. Global Truncus Arteriosus Market, By Diagnosis

7.1 Introduction

7.2 Echocardiogram

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 X-Ray

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Others

7.4.1 Market Estimates & Forecast, 2020-2027

8. Global Truncus Arteriosus Market, By Treatment

8.1 Introduction

8.2 Medication

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Surgery

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Cardiac Catheterization

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Others

8.5.1 Market Estimates & Forecast, 2020-2027

9. Global Truncus Arteriosus Market, By End User

9.1 Introduction

9.2 Hospitals & Clinics

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Cardiac Care Centers

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Others

9.4.1 Market Estimates & Forecast, 2020-2027

10. Global Truncus Arteriosus Market, By Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest Of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic Of Korea

10.4.6 Rest Of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest Of The Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12. Company Profiles

12.1 Boston Scientific Corporation

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Coloplast

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Dispocard GmbH

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 St. Jude Medical

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Abbott Laboratories

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.6 Johnson & Johnson

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Teleflex Incorporated

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Pharmaceutical Industry

14 Appendix

LIST OF TABLES

Table 1 Truncus Arteriosus Industry Synopsis, 2020-2027

Table 2 Global Truncus Arteriosus Market Estimates And Forecast, 2020-2027, (USD Million)

Table 3 Global Truncus Arteriosus Market By Region, 2020-2027, (USD Million)

Table 4 Global Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 5 Global Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 6 Global Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 7 Global Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

Table 8 North America Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 9 North America Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 10 North America Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 11 North America Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

Table 12 U.S. Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 13 U.S. Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 14 U.S. Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 15 U.S. Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

Table 16 Canada Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 17 Canada Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 18 Canada Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 19 Canada Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

Table 20 South America Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 21 South America Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 22 South America Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 23 South America Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

Table 24 Europe Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 25 Europe Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 26 Europe Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 27 Europe Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

Table 28 Western Europe Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 29 Western Europe Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 30 Western Europe Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 31 Western Europe Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 33 Eastern Europe Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 34 Eastern Europe Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 35 Eastern Europe Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 37 Asia Pacific Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 38 Asia Pacific Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 39 Asia Pacific Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Truncus Arteriosus Market By Types, 2020-2027, (USD Million)

Table 41 Middle East & Africa Truncus Arteriosus Market By Diagnosis, 2020-2027, (USD Million)

Table 42 Middle East & Africa Truncus Arteriosus Market By Treatment, 2020-2027, (USD Million)

Table 43 Middle East & Africa Truncus Arteriosus Market By End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Truncus Arteriosus Market

Figure 3 Segmentation Market Dynamics For Truncus Arteriosus Market

Figure 4 Global Truncus Arteriosus Market Share, By Diagnosis 2020

Figure 5 Global Truncus Arteriosus Market Share, By End Users, 2020

Figure 6 Global Truncus Arteriosus Market Share, By Region, 2020

Figure 7 North America Truncus Arteriosus Market Share, By Country, 2020

Figure 8 Europe Truncus Arteriosus Market Share, By Country, 2020

Figure 9 Asia Pacific Truncus Arteriosus Market Share, By Country, 2020

Figure 10 Middle East & Africa Truncus Arteriosus Market Share, By Country, 2020

Figure 11 Global Truncus Arteriosus Market: Company Share Analysis, 2020 (%)

Figure 12 Boston Scientific Corporation: Key Financials

Figure 13 Boston Scientific Corporation: Segmental Revenue

Figure 14 Boston Scientific Corporation: Geographical Revenue

Figure 15 Coloplast: Key Financials

Figure 16 Coloplast: Segmental Revenue

Figure 17 Coloplast: Geographical Revenue

Figure 18 Dispocard GmbH: Key Financials

Figure 19 Dispocard GmbH: Segmental Revenue

Figure 20 Dispocard GmbH: Geographical Revenue

Figure 21 St. Jude Medical: Key Financials

Figure 22 St. Jude Medical: Segmental Revenue

Figure 23 St. Jude Medical: Geographical Revenue

Figure 24 Abbott Laboratories.: Key Financials

Figure 25 Abbott Laboratories: Segmental Revenue

Figure 26 Abbott Laboratories: Geographical Revenue

Figure 27 Johnson & Johnson: Key Financials

Figure 28 Johnson & Johnson: Segmental Revenue

Figure 29 Johnson & Johnson: Geographical Revenue

Figure 30 Teleflex Incorporated.: Key Financials

Figure 31 Teleflex Incorporated: Segmental Revenue

Figure 32 Teleflex Incorporated: Geographical Revenue